Ajovy is a calcitonin gene-related peptide antagonist approved for pediatric episodic migraine prevention and migraine ...

Menstrual migraines tend to last longer, resist treatment, and cause greater disability. While some women experience relief ...

Recently, the Virtual Headache Specialist was awarded the Best Online On-Demand Migraine Masterclass for Migraine Patients ...

DARIEN, Conn., Aug. 13, 2025 /PRNewswire/ -- CEFALY Technology, the maker of FDA-cleared migraine treatment devices, today announced that Haven Headache & Migraine Center has joined the CEFALY ...

Chronic headaches are an unnerving and often debilitating condition experienced by more than a billion people worldwide. Why ...

The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive ...

More than 1.2 billion people worldwide suffer from migraine and other debilitating conditions that are under-studied and ...

IT HAPPENED IN THE LOBBY OF AN OMAHA MOVIE THEATER, AND SOMEONE CAUGHT SOME OF THE ATTACK ON THEIR CELL PHONE. NOW, POLICE TURNED TO KETV CRIME STOPPERS, HOPING TO CATCH THE ATTACKERS.

Teva's Ajovy gains FDA approval for pediatric migraine prevention, offering hope for children aged 6-17 with this ...

Rising temperatures can mean rising pain for many people, as summer heat can often trigger the onset of migraine headaches.

LONDON (AP) — Ozzy Osbourne died of a heart attack and had coronary artery disease in addition to suffering from Parkinson’s disease for years, his death certificate said. The singer had ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM) Q2 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Ari Maizel - Chief Commercial Officer Darren Opland - Corporate Participant ...